nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluticasone furoate—ABCB1—Dactinomycin—muscle cancer	0.232	0.258	CbGbCtD
Fluticasone furoate—ABCB1—Vincristine—muscle cancer	0.143	0.159	CbGbCtD
Fluticasone furoate—ABCB1—Etoposide—muscle cancer	0.131	0.146	CbGbCtD
Fluticasone furoate—ABCB1—Doxorubicin—muscle cancer	0.0894	0.0993	CbGbCtD
Fluticasone furoate—ABCB1—Methotrexate—muscle cancer	0.0866	0.0962	CbGbCtD
Fluticasone furoate—CYP3A4—Vincristine—muscle cancer	0.0857	0.0952	CbGbCtD
Fluticasone furoate—CYP3A4—Etoposide—muscle cancer	0.0785	0.0873	CbGbCtD
Fluticasone furoate—CYP3A4—Doxorubicin—muscle cancer	0.0536	0.0595	CbGbCtD
Fluticasone furoate—Growth retardation—Dactinomycin—muscle cancer	0.012	0.12	CcSEcCtD
Fluticasone furoate—Prolonged menses—Vincristine—muscle cancer	0.0116	0.117	CcSEcCtD
Fluticasone furoate—Menorrhagia—Vincristine—muscle cancer	0.00328	0.033	CcSEcCtD
Fluticasone furoate—Ulcer—Dactinomycin—muscle cancer	0.00288	0.0289	CcSEcCtD
Fluticasone furoate—Impaired healing—Methotrexate—muscle cancer	0.00273	0.0274	CcSEcCtD
Fluticasone furoate—Ulcer—Etoposide—muscle cancer	0.00208	0.0209	CcSEcCtD
Fluticasone furoate—Vaginal moniliasis—Doxorubicin—muscle cancer	0.00202	0.0203	CcSEcCtD
Fluticasone furoate—Vulvovaginal candidiasis—Doxorubicin—muscle cancer	0.00194	0.0195	CcSEcCtD
Fluticasone furoate—Candida infection—Etoposide—muscle cancer	0.00188	0.0189	CcSEcCtD
Fluticasone furoate—Vulvovaginal mycotic infection—Doxorubicin—muscle cancer	0.00187	0.0188	CcSEcCtD
Fluticasone furoate—Pharyngitis—Dactinomycin—muscle cancer	0.00136	0.0136	CcSEcCtD
Fluticasone furoate—Herpes simplex—Methotrexate—muscle cancer	0.00128	0.0129	CcSEcCtD
Fluticasone furoate—Ulcer—Methotrexate—muscle cancer	0.00125	0.0125	CcSEcCtD
Fluticasone furoate—Dysphonia—Doxorubicin—muscle cancer	0.00124	0.0125	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Vincristine—muscle cancer	0.0012	0.0121	CcSEcCtD
Fluticasone furoate—Herpes simplex—Doxorubicin—muscle cancer	0.00111	0.0111	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Vincristine—muscle cancer	0.0011	0.0111	CcSEcCtD
Fluticasone furoate—Ulcer—Doxorubicin—muscle cancer	0.00108	0.0109	CcSEcCtD
Fluticasone furoate—Atrioventricular block—Doxorubicin—muscle cancer	0.00105	0.0106	CcSEcCtD
Fluticasone furoate—Back pain—Vincristine—muscle cancer	0.00103	0.0103	CcSEcCtD
Fluticasone furoate—Agitation—Vincristine—muscle cancer	0.000977	0.00982	CcSEcCtD
Fluticasone furoate—Candida infection—Doxorubicin—muscle cancer	0.000975	0.0098	CcSEcCtD
Fluticasone furoate—Infection—Dactinomycin—muscle cancer	0.000964	0.00969	CcSEcCtD
Fluticasone furoate—Eye disorder—Etoposide—muscle cancer	0.000924	0.00929	CcSEcCtD
Fluticasone furoate—Visual disturbance—Methotrexate—muscle cancer	0.000904	0.00908	CcSEcCtD
Fluticasone furoate—Immune system disorder—Etoposide—muscle cancer	0.000893	0.00898	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Etoposide—muscle cancer	0.000891	0.00896	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Vincristine—muscle cancer	0.000867	0.00872	CcSEcCtD
Fluticasone furoate—Infection—Vincristine—muscle cancer	0.000862	0.00866	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Vincristine—muscle cancer	0.000851	0.00855	CcSEcCtD
Fluticasone furoate—Back pain—Etoposide—muscle cancer	0.000833	0.00837	CcSEcCtD
Fluticasone furoate—Body temperature increased—Dactinomycin—muscle cancer	0.000767	0.00771	CcSEcCtD
Fluticasone furoate—Cough—Etoposide—muscle cancer	0.000751	0.00755	CcSEcCtD
Fluticasone furoate—Migraine—Doxorubicin—muscle cancer	0.00073	0.00734	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Dactinomycin—muscle cancer	0.000715	0.00719	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Etoposide—muscle cancer	0.000703	0.00706	CcSEcCtD
Fluticasone furoate—Infection—Etoposide—muscle cancer	0.000698	0.00702	CcSEcCtD
Fluticasone furoate—Body temperature increased—Vincristine—muscle cancer	0.000686	0.00689	CcSEcCtD
Fluticasone furoate—Diarrhoea—Dactinomycin—muscle cancer	0.000664	0.00668	CcSEcCtD
Fluticasone furoate—Nasopharyngitis—Doxorubicin—muscle cancer	0.000663	0.00666	CcSEcCtD
Fluticasone furoate—Conjunctivitis—Methotrexate—muscle cancer	0.000641	0.00645	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Vincristine—muscle cancer	0.000639	0.00642	CcSEcCtD
Fluticasone furoate—Dyspnoea—Etoposide—muscle cancer	0.000626	0.0063	CcSEcCtD
Fluticasone furoate—Epistaxis—Methotrexate—muscle cancer	0.000622	0.00626	CcSEcCtD
Fluticasone furoate—Bronchitis—Doxorubicin—muscle cancer	0.000616	0.0062	CcSEcCtD
Fluticasone furoate—Rash—Dactinomycin—muscle cancer	0.000612	0.00615	CcSEcCtD
Fluticasone furoate—Diarrhoea—Vincristine—muscle cancer	0.000593	0.00597	CcSEcCtD
Fluticasone furoate—Pharyngitis—Methotrexate—muscle cancer	0.000588	0.00591	CcSEcCtD
Fluticasone furoate—Nausea—Dactinomycin—muscle cancer	0.000577	0.0058	CcSEcCtD
Fluticasone furoate—Dizziness—Vincristine—muscle cancer	0.000574	0.00577	CcSEcCtD
Fluticasone furoate—Visual impairment—Methotrexate—muscle cancer	0.000571	0.00574	CcSEcCtD
Fluticasone furoate—Urticaria—Etoposide—muscle cancer	0.000558	0.00561	CcSEcCtD
Fluticasone furoate—Body temperature increased—Etoposide—muscle cancer	0.000555	0.00558	CcSEcCtD
Fluticasone furoate—Conjunctivitis—Doxorubicin—muscle cancer	0.000555	0.00558	CcSEcCtD
Fluticasone furoate—Eye disorder—Methotrexate—muscle cancer	0.000554	0.00556	CcSEcCtD
Fluticasone furoate—Rash—Vincristine—muscle cancer	0.000547	0.0055	CcSEcCtD
Fluticasone furoate—Dermatitis—Vincristine—muscle cancer	0.000546	0.00549	CcSEcCtD
Fluticasone furoate—Headache—Vincristine—muscle cancer	0.000543	0.00546	CcSEcCtD
Fluticasone furoate—Epistaxis—Doxorubicin—muscle cancer	0.000539	0.00542	CcSEcCtD
Fluticasone furoate—Immune system disorder—Methotrexate—muscle cancer	0.000535	0.00538	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Methotrexate—muscle cancer	0.000534	0.00537	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Etoposide—muscle cancer	0.000518	0.0052	CcSEcCtD
Fluticasone furoate—Nausea—Vincristine—muscle cancer	0.000515	0.00518	CcSEcCtD
Fluticasone furoate—Pharyngitis—Doxorubicin—muscle cancer	0.000509	0.00512	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Doxorubicin—muscle cancer	0.000504	0.00507	CcSEcCtD
Fluticasone furoate—Back pain—Methotrexate—muscle cancer	0.000499	0.00501	CcSEcCtD
Fluticasone furoate—Visual impairment—Doxorubicin—muscle cancer	0.000494	0.00497	CcSEcCtD
Fluticasone furoate—Diarrhoea—Etoposide—muscle cancer	0.000481	0.00483	CcSEcCtD
Fluticasone furoate—Eye disorder—Doxorubicin—muscle cancer	0.000479	0.00482	CcSEcCtD
Fluticasone furoate—Dizziness—Etoposide—muscle cancer	0.000465	0.00467	CcSEcCtD
Fluticasone furoate—Immune system disorder—Doxorubicin—muscle cancer	0.000463	0.00466	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Doxorubicin—muscle cancer	0.000462	0.00465	CcSEcCtD
Fluticasone furoate—Cough—Methotrexate—muscle cancer	0.00045	0.00452	CcSEcCtD
Fluticasone furoate—Rash—Etoposide—muscle cancer	0.000443	0.00445	CcSEcCtD
Fluticasone furoate—Dermatitis—Etoposide—muscle cancer	0.000443	0.00445	CcSEcCtD
Fluticasone furoate—Headache—Etoposide—muscle cancer	0.00044	0.00442	CcSEcCtD
Fluticasone furoate—Back pain—Doxorubicin—muscle cancer	0.000432	0.00434	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Methotrexate—muscle cancer	0.000421	0.00423	CcSEcCtD
Fluticasone furoate—Infection—Methotrexate—muscle cancer	0.000418	0.0042	CcSEcCtD
Fluticasone furoate—Nausea—Etoposide—muscle cancer	0.000417	0.0042	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Methotrexate—muscle cancer	0.000413	0.00415	CcSEcCtD
Fluticasone furoate—Agitation—Doxorubicin—muscle cancer	0.00041	0.00412	CcSEcCtD
Fluticasone furoate—Palpitations—Doxorubicin—muscle cancer	0.000395	0.00397	CcSEcCtD
Fluticasone furoate—Cough—Doxorubicin—muscle cancer	0.00039	0.00392	CcSEcCtD
Fluticasone furoate—Dyspnoea—Methotrexate—muscle cancer	0.000375	0.00377	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Doxorubicin—muscle cancer	0.000364	0.00366	CcSEcCtD
Fluticasone furoate—Infection—Doxorubicin—muscle cancer	0.000362	0.00364	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Doxorubicin—muscle cancer	0.000357	0.00359	CcSEcCtD
Fluticasone furoate—Urticaria—Methotrexate—muscle cancer	0.000334	0.00336	CcSEcCtD
Fluticasone furoate—Body temperature increased—Methotrexate—muscle cancer	0.000333	0.00334	CcSEcCtD
Fluticasone furoate—Dyspnoea—Doxorubicin—muscle cancer	0.000325	0.00327	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Methotrexate—muscle cancer	0.00031	0.00312	CcSEcCtD
Fluticasone furoate—Urticaria—Doxorubicin—muscle cancer	0.00029	0.00291	CcSEcCtD
Fluticasone furoate—Body temperature increased—Doxorubicin—muscle cancer	0.000288	0.0029	CcSEcCtD
Fluticasone furoate—Diarrhoea—Methotrexate—muscle cancer	0.000288	0.00289	CcSEcCtD
Fluticasone furoate—Dizziness—Methotrexate—muscle cancer	0.000278	0.0028	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Doxorubicin—muscle cancer	0.000269	0.0027	CcSEcCtD
Fluticasone furoate—Rash—Methotrexate—muscle cancer	0.000265	0.00267	CcSEcCtD
Fluticasone furoate—Dermatitis—Methotrexate—muscle cancer	0.000265	0.00266	CcSEcCtD
Fluticasone furoate—Headache—Methotrexate—muscle cancer	0.000264	0.00265	CcSEcCtD
Fluticasone furoate—Nausea—Methotrexate—muscle cancer	0.00025	0.00251	CcSEcCtD
Fluticasone furoate—Diarrhoea—Doxorubicin—muscle cancer	0.000249	0.00251	CcSEcCtD
Fluticasone furoate—Dizziness—Doxorubicin—muscle cancer	0.000241	0.00242	CcSEcCtD
Fluticasone furoate—Rash—Doxorubicin—muscle cancer	0.00023	0.00231	CcSEcCtD
Fluticasone furoate—Dermatitis—Doxorubicin—muscle cancer	0.00023	0.00231	CcSEcCtD
Fluticasone furoate—Headache—Doxorubicin—muscle cancer	0.000228	0.00229	CcSEcCtD
Fluticasone furoate—Nausea—Doxorubicin—muscle cancer	0.000216	0.00218	CcSEcCtD
Fluticasone furoate—Triamcinolone—PTGS2—muscle cancer	0.000152	0.436	CrCbGaD
Fluticasone furoate—Betamethasone—PTGS2—muscle cancer	0.000124	0.357	CrCbGaD
Fluticasone furoate—Dexamethasone—PTGS2—muscle cancer	7.23e-05	0.208	CrCbGaD
